The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Should Medicare and Medicaid eventually cover new weight loss drugs such as Ozempic and Wegovy? This week, Audacy took a look ...

A report published in November by KFF, a health information nonprofit that includes KFF Health News, found only 13 states were covering GLP-1s for the treatment of obesity for Medicaid beneficiaries ...

The Cigna Group (NYSE:CI)’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Expanding coverage of the drugs would have ... In an effort to reduce costs, Medicare has selected Novo Nordisk’s Wegovy for negotiations to lower prices under a law passed by a Democratic ...

(Medicare last year opened the door to coverage of Wegovy for Medicare enrollees with cardiovascular disease who are either overweight or have obesity.) But it will be up to the Trump ...

The new round of talks come as the Biden administration has also proposed expanding Medicare coverage to weight loss ... criticized Medicare's grouping of Wegovy, Ozempic and Rybelsus together ...